Recombinant human interleukin-2 (Changchun ChangSheng Gene Pharmaceutical)

重组人白细胞介素-2（长春长生基因药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human interleukin-2 (Changchun ChangSheng Gene Pharmaceutical)
Drug Alias NameIL-2 (Changchun ChangSheng Gene Pharmaceutical)安特鲁克Anteluke
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsAscitesAutoimmune DiseasesNeoplasms +[4] 
Global Approved IndicationsAscitesAutoimmune DiseasesNeoplasms +[4] 
Approved Indications in ChinaAscitesAutoimmune DiseasesNeoplasms +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
Inactive CompaniesN/A
Active IndicationsAscitesAutoimmune DiseasesNeoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AC01
Related LinksN/A